	Prospectos 1 661 1 9640,	
co 1 661 1 9639,	
20 1 661 1 8829,	
16 1 661 1 6734,	
interrumpisrse 1 661 1 6672,	
4)Si 1 661 1 6244,	
beige 1 661 1 5976,	
eu/ 1 661 1 5919,	
europa 1 661 1 5918,	
emea 1 661 1 5917,	
//www 1 661 1 5916,	
http 1 661 1 5915,	
Medicamento 1 661 1 5913,	
Europea 1 661 1 5911,	
Agencia 1 661 1 5910,	
web 1 661 1 5907,	
detallada 1 661 1 5898,	
TEXTO 1 661 1 5895,	
2007 1 661 1 5888,	
21 2 661 2 5884,9577,	
autorización 1 661 1 5883,	
AUTORIZACIÓN/RENOVACIÓN 1 661 1 5875,	
PRIMERA 1 661 1 5874,	
FECHA 2 661 2 5871,5890,	
EU/1/07/382/006 1 661 1 5869,	
EU/1/07/382/005 1 661 1 5868,	
EU/1/07/382/004 1 661 1 5867,	
EU/1/07/382/003 1 661 1 5866,	
EU/1/07/382/002 1 661 1 5865,	
EU/1/07/382/001 1 661 1 5864,	
NÚMERO(S) 1 661 1 5859,	
Unido 1 661 1 5857,	
Reino 1 661 1 5856,	
9BU 1 661 1 5855,	
Hertfordshire 1 661 1 5853,	
Hertford 1 661 1 5850,	
Ltd 1 661 1 5849,	
Dohme 1 661 1 5848,	
& 1 661 1 5847,	
	Merck 1 661 1 5845,	
COMERCIALIZACIÓN 2 661 2 5844,5863,	
AUTORIZACIÓN 3 661 3 5842,5861,5878,	
LA 4 661 4 5841,5873,5877,5892,	
local 1 661 1 5837,	
acuerdo 1 661 1 5833,	
realizará 1 661 1 5831,	
contacto 1 661 1 5827,	
hayan 1 661 1 5824,	
materiales 1 661 1 5822,	
utilizado 1 661 1 5817,	
tamaños 1 661 1 5803,	
comercializados 1 661 1 5801,	
estén 1 661 1 5800,	
Puede 1 661 1 5797,	
perforados 1 661 1 5796,	
monodosis 1 661 1 5795,	
blísters 1 661 1 5794,	
98 1 661 1 5780,	
ó 1 661 1 5779,	
84 1 661 1 5778,	
56 1 661 1 5777,	
28 1 661 1 5776,	
Envases 1 661 1 5773,	
EN11 1 661 1 5854,	
(PVC/PE/PVDC 1 661 1 5770,	
envase 1 661 1 5767,	
contenido 1 661 1 5765,	
condiciones 1 661 1 5757,	
conservación 2 661 2 5752,5760,	
Precauciones 2 661 2 5749,5808,	
validez 1 661 1 5744,	
procede 1 661 1 5739,	
amarillo 1 661 1 5733,	
rojo 1 661 1 5728,	
hierro 2 661 2 5727,5732,	
óxido 2 661 2 5725,5730,	
(E171) 1 661 1 5724,	
titanio 1 661 1 5723,	
dióxido 1 661 1 5721,	
(E553b) 1 661 1 5720,	
talco 1 661 1 5719,	
3350 1 661 1 5718,	
macrogol 1 661 1 5717,	
polivinílico 1 661 1 5716,	
alcohol 1 661 1 5715,	
Cubierta 1 661 1 5713,	
sodio 1 661 1 5712,	
estearilo 1 661 1 5710,	
(E470b) 1 661 1 5707,	
estearato 1 661 1 5704,	
(E468) 1 661 1 5703,	
sódica 1 661 1 5702,	
croscarmelosa 1 661 1 5701,	
(E341) 1 661 1 5700,	
anhidro 1 661 1 5699,	
calcio 1 661 1 5698,	
hidrogenofosfato 1 661 1 5696,	
microcristalina 1 661 1 5694,	
celulosa 1 661 1 5693,	
Núcleo 1 661 1 5690,	
Lista 1 661 1 5687,	
	6 1 661 1 5685,	
FARMACÉUTICOS 1 661 1 5684,	
leche/plasma 1 661 1 5678,	
(relación 1 661 1 5677,	
cantidades 1 661 1 5675,	
lactantes 1 661 1 5673,	
márgenes 1 661 1 5651,	
Considerando 1 661 1 5648,	
29 2 661 2 5626,5643,	
crías 1 661 1 5615,	
hipoplásicas 1 661 1 5610,	
(costillas 1 661 1 5608,	
fetales 1 661 1 5603,	
costales 1 661 1 5602,	
malformaciones 1 661 1 5601,	
reproducción 2 661 2 5592,5663,	
mostró 1 661 1 5583,	
postnatal 1 661 1 5576,	
pre 1 661 1 5574,	
desarrollo 1 661 1 5573,	
apareamiento 1 661 1 5567,	
recibieron 1 661 1 5561,	
hembra 1 661 1 5559,	
macho 1 661 1 5557,	
consideran 1 661 1 5537,	
neoplásicas 1 661 1 5534,	
alteraciones 1 661 1 5533,	
hallazgo) 1 661 1 5531,	
(19 1 661 1 5522,	
margen 1 661 1 5519,	
alta 1 661 1 5515,	
secundaria 1 661 1 5506,	
rata 2 661 2 5503,5580,	
tumores 1 661 1 5499,	
hepáticas 1 661 1 5489,	
inducción 1 661 1 5486,	
correlaciona 1 661 1 5481,	
Dado 2 661 2 5478,5516,	
hepáticos 2 661 2 5465,5500,	
carcinomas 1 661 1 5464,	
adenomas 1 661 1 5462,	
produjo 1 661 1 5455,	
ratón 1 661 1 5451,	
carcinógena 1 661 1 5448,	
preclínicos 1 661 1 5444,	
genotoxicidad 1 661 1 5440,	
correspondiente 2 661 2 5429,5622,	
dieron 1 661 1 5403,	
esqueléticos 1 661 1 5399,	
músculos 1 661 1 5398,	
degeneración 1 661 1 5392,	
histológicos 1 661 1 5390,	
encorvada 1 661 1 5384,	
postura 1 661 1 5383,	
y/o 1 661 1 5382,	
temblor 1 661 1 5378,	
blancos 1 661 1 5376,	
espumosos 1 661 1 5375,	
vómitos 1 661 1 5374,	
salivación 1 661 1 5373,	
abierta 1 661 1 5372,	
boca 1 661 1 5371,	
respiración 1 661 1 5368,	
sugirieron 1 661 1 5363,	
pasajeros 1 661 1 5354,	
físicos 1 661 1 5353,	
signos 2 661 2 5352,5389,	
23 2 661 2 5344,5412,	
perro 1 661 1 5337,	
importancia 1 661 1 5327,	
correspondió 1 661 1 5314,	
base 1 661 1 5298,	
67 1 661 1 5292,	
ratas 7 661 7 5285,5306,5453,5492,5556,5617,5672,	
incisivos 1 661 1 5283,	
anomalías 1 661 1 5280,	
19 2 661 2 5273,8269,	
58 3 661 3 5260,5319,5473,	
correspondientes 5 661 5 5258,5290,5409,5471,5639,	
sistémica 3 661 3 5257,5470,5621,	
roedores 1 661 1 5252,	
observado 2 661 2 5246,5351,	
Road 1 661 1 5851,	
preclinicos 1 661 1 5241,	
Datos 1 661 1 5240,	
farmacocinéticos 1 661 1 5220,	
(IMC) 1 661 1 5199,	
masa 1 661 1 5197,	
índice 1 661 1 5195,	
raza 1 661 1 5192,	
sexo 1 661 1 5190,	
características 2 661 2 5175,5201,	
Otras 1 661 1 5174,	
pediátricos 1 661 1 5173,	
Niños 1 661 1 5163,	
jóvenes 1 661 1 5162,	
19% 1 661 1 5156,	
(65 1 661 1 5144,	
II 2 661 2 5138,5237,	
I 3 661 3 5135,5223,5234,	
fase 5 661 5 5134,5137,5222,5233,5236,	
juzgar 2 661 2 5123,5213,	
Ancianos 1 661 1 5095,	
altere 1 661 1 5089,	
dado 1 661 1 5072,	
existe 1 661 1 5056,	
9) 2 661 2 5054,5069,	
Child-Pugh 2 661 2 5053,5067,	
(puntuación 2 661 2 5051,5065,	
(13 1 661 1 4976,	
precisen 1 661 1 4957,	
cuadriplicó 1 661 1 4941,	
duplicó 1 661 1 4937,	
concentración 1 661 1 4908,	
presentaron 2 661 2 4903,5148,	
así 1 661 1 4888,	
(30 1 661 1 4878,	
80 2 661 2 4875,5146,	
según 1 661 1 4865,	
clasificada 1 661 1 4864,	
incluyó 1 661 1 4858,	
grados 1 661 1 4843,	
diversos 1 661 1 4842,	
(50 2 661 2 4837,4872,	
(E460) 1 661 1 5695,	
abierto 1 661 1 4823,	
Características 1 661 1 4793,	
ligero 2 661 2 4787,5595,	
terapéuticamente 1 661 1 4763,	
250 1 661 1 4758,	
(hasta 1 661 1 4757,	
M) 2 661 2 4748,4759,	
(CI50=160 1 661 1 4747,	
inhibió 1 661 1 4745,	
PEPT1/2 1 661 1 4740,	
transportadores 1 661 1 4739,	
considerables 1 661 1 5676,	
OAT1 1 661 1 4735,	
redujo 1 661 1 4722,	
intervenir 1 661 1 4704,	
hOAT-3 1 661 1 4687,	
clínica 4 661 4 4685,5058,5348,5435,	
relevancia 1 661 1 4684,	
participar 1 661 1 4672,	
(hOAT-3) 1 661 1 4669,	
aniones 1 661 1 4665,	
substrato 1 661 1 4661,	
tubular 1 661 1 4656,	
comporta 1 661 1 4654,	
principalmente 2 661 2 4649,5077,	
produce 1 661 1 4648,	
ml/min 1 661 1 4642,	
350 1 661 1 4641,	
mínima 1 661 1 4631,	
acumula 1 661 1 4628,	
12 1 661 1 4622,	
aparente 1 661 1 4609,	
t1/2 1 661 1 4607,	
siguiente 1 661 1 4602,	
(13%) 1 661 1 4593,	
heces 1 661 1 4592,	
100% 1 661 1 4583,	
Eliminación 1 661 1 4567,	
hallazgos 3 661 3 5330,5423,5655,	
CYP1A2 1 661 1 4566,	
inductor 1 661 1 4562,	
2B6 1 661 1 4557,	
2C19 1 661 1 4555,	
1A2 1 661 1 4554,	
2D6 1 661 1 4553,	
2C9 1 661 1 4552,	
2C8 1 661 1 4551,	
CYP 1 661 1 4549,	
muestran 1 661 1 4539,	
participación 1 661 1 4531,	
ejerce 1 661 1 4510,	
plasma 1 661 1 4508,	
inhibitoria 1 661 1 4503,	
contribuyan 1 661 1 4499,	
espera 1 661 1 4497,	
traza 1 661 1 4493,	
seis 1 661 1 4489,	
detectaron 1 661 1 4488,	
metabolitos 2 661 2 4484,4490,	
excretó 1 661 1 4480,	
radiactividad 2 661 2 4478,4586,	
16% 1 661 1 4475,	
Hoddesdon 1 661 1 5852,	
[C14] 2 661 2 4471,4576,	
79% 1 661 1 4455,	
Aproximadamente 1 661 1 4453,	
orina 3 661 3 4446,4464,4597,	
modificar 2 661 2 4443,4461,	
fundamentalmente 1 661 1 4441,	
elimina 2 661 2 4440,5076,	
Metabolismo 1 661 1 4437,	
(38%) 1 661 1 4436,	
reversiblemente 1 661 1 4429,	
unida 1 661 1 4428,	
fracción 1 661 1 4425,	
intravenosa 1 661 1 4410,	
estacionario 1 661 1 4401,	
distribución 1 661 1 4398,	
volumen 1 661 1 4395,	
Distribución 1 661 1 4393,	
dosis) 2 661 2 4392,4995,	
C24h 2 661 2 4364,4382,	
proporcionalidad 3 661 3 4358,4376,4389,	
establecido 2 661 2 4356,4682,	
198 1 661 1 4422,	
proporcional 1 661 1 4349,	
administrase 1 661 1 4336,	
grasa 1 661 1 4327,	
Puesto 1 661 1 4316,	
87% 1 661 1 4315,	
absoluta 1 661 1 4308,	
950 1 661 1 4304,	
M·hr 1 661 1 4299,	
52 1 661 1 4298,	
Tmax) 1 661 1 4280,	
(mediana 1 661 1 4278,	
mediando 1 661 1 4705,	
máximas 1 661 1 4277,	
alcanzándose 1 661 1 4274,	
absorbió 1 661 1 4272,	
Absorción 1 661 1 4256,	
0%) 1 661 1 4251,	
(32 1 661 1 4250,	
menor 3 661 3 4243,4386,4452,	
9%) 1 661 1 4240,	
(4 1 661 1 4239,	
eficiencia 1 661 1 4210,	
marcador 1 661 1 4207,	
kg) 1 661 1 4196,	
significativo 2 661 2 4183,4913,	
(87%) 1 661 1 4598,	
interrumpieron 1 661 1 4142,	
mg/día 1 661 1 4129,	
requirieron 1 661 1 4121,	
40% 1 661 1 4117,	
día; 1 661 1 4114,	
comparador 1 661 1 4108,	
farmacocinéticas 1 661 1 4255,	
usada 1 661 1 4104,	
inadecuado 1 661 1 4079,	
sulfonilurea) 1 661 1 4072,	
(una 1 661 1 4071,	
semana 2 661 2 4044,4601,	
001 1 661 1 4030,	
p<0 1 661 1 4029,	
anterior 1 661 1 4024,	
antihiperglucémico 1 661 1 4023,	
ajustada 1 661 1 4017,	
página 1 661 1 5906,	
cuadrados 1 661 1 4016,	
tratar) 1 661 1 4012,	
intención 1 661 1 4010,	
análisis 4 661 4 4008,5126,5216,5226,	
(un 1 661 1 4007,	
tratada 1 661 1 4006,	
(N=183) 1 661 1 3981,	
500 1 661 1 3979,	
-1 2 661 2 3976,3994,	
(dos 2 661 2 3966,3984,	
(N=115) 1 661 1 3951,	
+ 4 661 4 3949,3973,3991,4036,	
7) 1 661 1 3942,	
(N=163) 1 661 1 3903,	
229) 1 661 1 3851,	
6) 1 661 1 3849,	
(-1 3 661 3 3846,3939,4190,	
193) 1 661 1 3834,	
(N= 2 661 2 3833,3850,	
-0 12 661 12 3822,3831,3840,3848,3862,3871,3885,3894,3909,3918,3932,3941,	
(%) 3 661 3 3811,3961,4041,	
Media 3 661 3 3803,3953,4013,	
Ensayo 2 661 2 3802,3952,	
combinación* 1 661 1 3801,	
Resultados 1 661 1 3786,	
grupos 1 661 1 3781,	
placebo; 1 661 1 3759,	
neoplasias 1 661 1 5488,	
(500 2 661 2 3718,9602,	
factorial 2 661 2 3697,9581,	
modesta 3 661 3 3683,4973,9566,	
ganancia 2 661 2 3682,9565,	
años) 1 661 1 5147,	
obtuvieron 2 661 2 3680,9563,	
siptagliptina 2 661 2 3679,9562,	
día) 6 661 6 3642,3726,3969,3987,9525,9610,	
(100 2 661 2 3637,9520,	
diseñó 2 661 2 3620,9503,	
notificada 2 661 2 3610,9493,	
hubo 3 661 3 3604,3761,9487,	
comparados 2 661 2 3553,9436,	
glucémicos 4 661 4 3552,3674,9435,9557,	
mejorías 4 661 4 3547,3670,9430,9553,	
proporcionó 4 661 4 3546,3669,9429,9552,	
seguro 2 661 2 3531,9414,	
confirmar 2 661 2 3528,9411,	
observadas 2 661 2 3497,9380,	
magnesio 1 661 1 5706,	
proteínas 1 661 1 4432,	
generalmente 2 661 2 3493,9376,	
GPA 2 661 2 3486,9369,	
HbA1C 2 661 2 3483,9366,	
reducidas 2 661 2 3466,9349,	
tolerabilidad 2 661 2 3463,9346,	
investigaron 2 661 2 3458,9341,	
crónica 4 661 4 3450,4847,5511,9333,	
ningún 3 661 3 3423,5113,9306,	
muestras 2 661 2 3391,9274,	
tolerancia 2 661 2 3386,9269,	
proinsulina 3 661 3 3370,4203,9253,	
Assessment-) 2 661 2 3367,9250,	
Model 2 661 2 3366,9249,	
(Homeostasis 2 661 2 3365,9248,	
HOMA- 2 661 2 3364,9247,	
(subrrogados) 2 661 2 3355,9238,	
disponible 1 661 1 5903,	
indirectos 2 661 2 3354,9237,	
marcadores 2 661 2 3353,9236,	
comparada 5 661 5 3331,3734,4031,9214,9618,	
GPP) 2 661 2 3330,9213,	
(2- 2 661 2 3328,9211,	
opacos 1 661 1 5769,	
(GPA) 2 661 2 3318,9201,	
logró 4 661 4 3305,3727,9188,9611,	
valoración 2 661 2 3270,9153,	
criterio 2 661 2 3268,9151,	
basales 2 661 2 3265,9148,	
HbA1c 7 661 7 3261,3311,3788,4040,4098,9144,9194,	
reducciones 4 661 4 3256,3480,9139,9363,	
medido 2 661 2 3254,9137,	
tiazolidindiona 2 661 2 3253,9136,	
adicional) 2 661 2 3238,9121,	
Naturaleza 1 661 1 5763,	
(tratamiento 2 661 2 3235,9118,	
utilizó 2 661 2 3230,9113,	
administró 2 661 2 3225,9108,	
mejoró 3 661 3 3220,4219,9103,	
DPP-9 2 661 2 3211,9094,	
DPP-8 2 661 2 3209,9092,	
estrechamente 2 661 2 3207,9090,	
enzimas 2 661 2 3206,9089,	
selectivo 2 661 2 3197,9080,	
altamente 2 661 2 3196,9079,	
incrementa 2 661 2 3163,9046,	
sulfonilureas 2 661 2 3160,9043,	
mecanismo 4 661 4 3149,3157,9032,9040,	
postprandial 4 661 4 3147,3323,9030,9206,	
ayunas 4 661 4 3145,3317,9028,9200,	
(HbA1c) 2 661 2 3140,9023,	
A1c 2 661 2 3139,9022,	
bajas 2 661 2 3135,9018,	
producen 2 661 2 3134,9017,	
hiperglucemia 2 661 2 3124,9007,	
presentan 2 661 2 3123,9006,	
comportamiento 2 661 2 3113,8996,	
(E172) 2 661 2 5729,5734,	
Al 2 661 2 3091,8974,	
hidrólisis 2 661 2 3068,8951,	
hepatotoxicidad 1 661 1 5483,	
evita 2 661 2 3066,8949,	
inactivos 2 661 2 3063,8946,	
productos 2 661 2 3062,8945,	
diferente 2 661 2 3155,9038,	
rápidamente 3 661 3 3056,4273,8939,	
actividad 4 661 4 3042,4502,5381,8925,	
altera 2 661 2 3032,8915,	
subidas 2 661 2 3020,8903,	
intensifica 2 661 2 3018,8901,	
estimulación 4 661 4 2990,3012,8873,8895,	
observa 2 661 2 2989,8872,	
manera 4 661 4 2980,4348,4972,8863,	
dependientes 2 661 2 2977,8860,	
glucemia 6 661 6 2967,2984,3733,8850,8867,9617,	
lugar 3 661 3 2961,5404,8844,	
dando 2 661 2 2960,8843,	
reducida 3 661 3 2956,4834,8839,	
producción 2 661 2 2955,8838,	
disminuidas 2 661 2 2945,8827,	
Concentraciones 2 661 2 2942,8824,	
secreción 7 661 7 2935,3000,3165,4655,8817,8883,9048,	
reduce 4 661 4 2933,3106,8815,8989,	
tisular 2 661 2 2927,8809,	
captación 2 661 2 2926,8808,	
aumenta 4 661 4 2924,3100,8806,8983,	
elevados 5 661 5 2923,2949,5650,8805,8832,	
Con 2 661 2 2918,8800,	
biosíntesis 2 661 2 2912,8794,	
estimular 4 661 4 2910,3092,8792,8975,	
grado 4 661 4 2900,3376,8782,9259,	
modelos 2 661 2 2890,8772,	
DPP-4 9 661 9 2888,3053,3075,3201,4506,8770,8936,8958,9084,	
cíclico 2 661 2 2878,8760,	
administrada 1 661 1 4587,	
AMP 2 661 2 2877,8759,	
poblacional 2 661 2 5129,5229,	
interviene 2 661 2 2875,8757,	
intracelulares 2 661 2 2871,8753,	
señalización 2 661 2 2870,8752,	
células 10 661 10 2865,2908,2940,3361,3381,8747,8790,8822,9244,9264,	
liberación 11 661 11 2860,2915,2993,3014,3102,4215,8742,8797,8876,8897,8985,	
síntesis 3 661 3 2858,4213,8740,	
GIP 10 661 10 2855,2974,3010,3047,3090,8737,8857,8893,8930,8973,	
GLP-1 18 661 18 2852,2882,2932,2971,3005,3008,3030,3044,3088,8734,8764,8814,8854,8888,8891,8913,8927,8971,	
elevadas 2 661 2 2850,8732,	
normales 7 661 7 2848,3189,4853,4920,4965,8730,9072,	
homeostasis 2 661 2 2838,8720,	
fisiológica 2 661 2 2835,8717,	
5) 2 661 2 3872,3895,	
regulación 2 661 2 2834,8716,	
participa 2 661 2 2831,8713,	
endógeno 2 661 2 2829,8711,	
forman 2 661 2 2824,8706,	
comida 3 661 3 3389,4324,9272,	
comidas 2 661 2 2821,8703,	
respuesta 8 661 8 2818,2902,3034,3378,8700,8784,8917,9261,	
aumentan 6 661 6 2816,2856,3079,8698,8738,8962,	
intestino 2 661 2 2807,8689,	
liberadas 2 661 2 2804,8686,	
aluminio) 1 661 1 5772,	
(GIP) 2 661 2 2802,8684,	
dependiente 6 661 6 2797,3115,3151,8680,8998,9034,	
insulinotrópico 2 661 2 2796,8679,	
polipéptido 2 661 2 2795,8678,	
(GLP-1) 2 661 2 2792,8675,	
similar 13 661 13 2788,3404,3590,3607,3751,3778,4089,4805,8671,9287,9473,9490,9635,	
péptido 2 661 2 2787,8670,	
incluidos 2 661 2 2785,8668,	
activas 6 661 6 2782,3086,3097,8665,8969,8980,	
incretinas 12 661 12 2781,2784,2823,3059,3072,3096,8664,8667,8705,8942,8955,8979,	
hormonas 6 661 6 2780,3058,3071,8663,8941,8954,	
mediada 2 661 2 2772,8655,	
clínica; 1 661 1 5296,	
podría 3 661 3 2770,4703,8653,	
observada 6 661 6 2766,3397,3754,8649,9280,9638,	
mejoría 8 661 8 2762,3307,3350,3729,8645,9190,9233,9613,	
dipeptidil-peptidasa 2 661 2 2758,8641,	
denominan 2 661 2 2754,8637,	
clase 2 661 2 2748,8631,	
pertenece 2 661 2 2745,8628,	
A10BH01 2 661 2 2743,8626,	
ATC 2 661 2 2742,8625,	
código 2 661 2 2741,8624,	
Grupo 2 661 2 2733,8616,	
farmacodinámicas 2 661 2 2732,8615,	
Propiedades 3 661 3 2731,4254,8614,	
	5 2 661 2 2729,8612,	
ESTE 2 661 2 2727,8610,	
FARMACOLÓGICAS 2 661 2 2725,8608,	
PROPIEDADES 2 661 2 2724,8607,	
diálisis 2 661 2 2721,8604,	
mediante 8 661 8 2720,2867,3255,4018,4974,8603,8749,9138,	
dializable 2 661 2 2719,8602,	
prolongada 2 661 2 2713,8596,	
apropiado 2 661 2 2708,8591,	
reducción 6 661 6 3429,3739,4095,4166,9312,9623,	
hemodiálisis 8 661 8 2699,2712,4895,4958,4975,4982,8582,8595,	
13 2 661 2 2690,8573,	
eliminó 4 661 4 2687,4589,4970,8570,	
dializa 2 661 2 2680,8563,	
instaurar 2 661 2 2673,8556,	
fumarato 1 661 1 5708,	
necesario 2 661 2 2672,8555,	
electrocardiograma) 2 661 2 2668,8551,	
seguimiento 2 661 2 2663,8546,	
realizar 2 661 2 2661,8544,	
digestivo 2 661 2 2660,8543,	
tubo 2 661 2 2659,8542,	
absorbido 2 661 2 2657,8540,	
eliminar 2 661 2 2653,8536,	
habituales 2 661 2 2650,8533,	
soporte 4 661 4 2649,2677,8532,8560,	
medidas 4 661 4 2647,3374,8530,9257,	
razonable 2 661 2 2644,8527,	
sobredosis 2 661 2 2642,8525,	
activa 1 661 1 4657,	
mayores 3 661 3 2631,5157,8514,	
relevantes 6 661 6 2625,3258,4764,5206,8508,9141,	
QTc 2 661 2 2619,8502,	
general 7 661 7 2599,3216,3472,4804,8482,9099,9355,	
800 6 661 6 2594,2610,2633,8477,8493,8516,	
hidroliza 2 661 2 3055,8938,	
únicas 3 661 3 2591,4826,8474,	
sanos 9 661 9 2588,4269,4418,4580,4808,4852,4919,4964,8471,	
sujetos 13 661 13 2587,3188,4268,4417,4579,4807,4851,4918,4963,5140,5160,8470,9071,	
Durante 2 661 2 2581,8464,	
) 2 661 2 2577,8460,	
urticaria 2 661 2 2561,8444,	
cutáneo 2 661 2 2560,8443,	
rash 2 661 2 2559,8442,	
conocida) 2 661 2 2552,8435,	
(frecuencia 2 661 2 2550,8433,	
post-comercialización 4 661 4 2538,2549,8421,8432,	
Experiencia 2 661 2 2537,8420,	
litros 1 661 1 4423,	
QTc) 2 661 2 2531,8414,	
intervalo 2 661 2 2530,8413,	
peptidasa 2 661 2 2739,8622,	
(incluido 2 661 2 2528,8411,	
ECG 2 661 2 2527,8410,	
vitales 2 661 2 2523,8406,	
relevante 4 661 4 2513,5116,5660,8396,	
(N=178) 1 661 1 3999,	
laboratorio 2 661 2 2508,8391,	
parámetros 6 661 6 2506,3551,3673,8389,9434,9556,	
cambio 4 661 4 2503,3580,8386,9463,	
Tratamiento 2 661 2 3964,3982,	
Este 3 661 3 2502,5753,8385,	
mayoría 2 661 2 2494,8377,	
halló 2 661 2 2491,8374,	
observación 2 661 2 2489,8372,	
Esta 2 661 2 2488,8371,	
neutrófilos 2 661 2 2487,8370,	
incremento 4 661 4 2485,4372,4385,8368,	
células/microlitro) 2 661 2 2481,8364,	
medio 8 661 8 2473,3806,3810,3956,3960,4292,4396,8356,	
basal 11 661 11 2472,3416,3588,3766,3804,3954,4028,4175,8355,9299,9471,	
células/microlitro; 2 661 2 2469,8352,	
200 2 661 2 2468,8351,	
(la 3 661 3 2458,4368,8341,	
leucocitos 6 661 6 2457,2461,2475,8340,8344,8358,	
recuento 2 661 2 2455,8338,	
observó 6 661 6 2450,3349,5425,5632,8333,9232,	
primariamente 2 661 2 2438,8321,	
relativas 2 661 2 2434,8317,	
diferencias 2 661 2 2433,8316,	
Fecha 1 661 1 5879,	
corporal 10 661 10 3411,3584,3686,3742,4171,5198,9294,9467,9569,9626,	
7%) 2 661 2 2430,8313,	
(6 2 661 2 2429,8312,	
una) 2 661 2 2423,8306,	
(14 2 661 2 2420,8303,	
comparable 2 661 2 2414,8297,	
exposición 18 661 18 5256,5263,5276,5289,5295,5317,5322,5341,5347,5408,5415,5428,5434,5469,5476,5620,5629,5646,	
global 4 661 4 2353,2392,8235,8275,	
mg) 3 661 3 2350,4838,8232,	
mg/1000 2 661 2 2349,8231,	
ausentes 1 661 1 5609,	
dipeptidil 2 661 2 2738,8621,	
mg/500 2 661 2 2345,8227,	
(sitagliptina/metformina 2 661 2 2343,8225,	
inicial 8 661 8 2334,3236,3706,3965,3983,8216,9119,9590,	
extremidades 2 661 2 2323,8205,	
artrosis 2 661 2 2318,8200,	
control) 2 661 2 2316,8198,	
respecto 4 661 4 2313,3414,8195,9297,	
>0 2 661 2 2311,8193,	
nivel 5 661 5 2297,5268,5418,5526,8179,	
(sin 2 661 2 2294,8176,	
conducen 2 661 2 2952,8835,	
ocurrieron 2 661 2 2284,8166,	
Acontecimientos 2 661 2 2270,8152,	
niveles 21 661 21 2778,2815,2920,2948,3094,3108,3129,3171,4492,5339,5406,5467,5638,8661,8697,8802,8831,8977,8991,9012,9054,	
nasofaringitis 2 661 2 2269,8151,	
resfriado 2 661 2 2267,8149,	
incluyeron 4 661 4 2266,2317,8148,8199,	
produjeron 4 661 4 2251,2303,8134,8185,	
medicación 4 661 4 2247,2281,8130,8163,	
causal 4 661 4 2244,2278,8127,8160,	
§ 2 661 2 3824,4046,	
independientemente 4 661 4 2240,2274,8123,8156,	
adicionales 4 661 4 2238,2272,8121,8154,	
acontecimientos 2 661 2 2236,8119,	
anteriormente 2 661 2 2234,8117,	
envases 1 661 1 5805,	
relacionados 3 661 3 2229,5355,8112,	
media 2 661 2 4101,4167,	
prueba 2 661 2 3384,9267,	
adversos 8 661 8 2228,2237,2271,5551,5585,8111,8120,8153,	
mareo 2 661 2 2223,8106,	
cefalea 2 661 2 2219,8102,	
pancreáticas 4 661 4 2866,2941,8748,8823,	
comparado 6 661 6 2177,3425,3687,8060,9308,9570,	
Además 11 661 11 2155,2224,2930,3028,3478,5385,8038,8107,8812,8911,9361,	
0% 6 661 6 2153,2385,2421,8036,8267,8304,	
placebo/pioglitazona 2 661 2 2145,8028,	
sitagliptina/pioglitazona 2 661 2 2137,8020,	
glimepirida/metformina 4 661 4 2079,2090,7962,7973,	
Sobredosis 2 661 2 2580,8463,	
6% 2 661 2 2034,7917,	
marzo 1 661 1 5886,	
11 3 661 3 2029,5094,7912,	
pequeña 2 661 2 3428,9311,	
placebo/glimepirida 2 661 2 2026,7909,	
sitagliptina/glimepirida 2 661 2 2019,7902,	
TITULAR 1 661 1 5839,	
glimepirida 14 661 14 2001,2055,3645,3649,3663,3666,3925,3948,7884,7938,9528,9532,9546,9549,	
complementarias; 2 661 2 1979,7862,	
(Exploraciones 2 661 2 1978,7861,	
peso 14 661 14 1977,3410,3431,3583,3685,3741,4170,4182,7860,9293,9314,9466,9568,9625,	
disminución 5 661 5 1975,2964,5379,7858,8847,	
+1 1 661 1 4194,	
frecuente) 4 661 4 1973,1981,7856,7864,	
nutrición; 2 661 2 1971,7854,	
(Trastornos 2 661 2 1965,7848,	
anorexia 2 661 2 1964,7847,	
siguientes 4 661 4 1963,2543,7846,8426,	
frente 9 661 9 1917,2462,3489,3763,4172,4192,7800,8345,9372,	
combinados 2 661 2 1907,7790,	
30 3 661 3 1902,4886,7785,	
Periodo 1 661 1 5742,	
14 6 661 6 1898,2384,5303,5775,7781,8266,	
sulfonilurea/metformina 4 661 4 1895,1920,7778,7803,	
Blísters 1 661 1 5768,	
año 4 661 4 1857,1911,7740,7794,	
(DPP-4) 4 661 4 2740,2760,8623,8643,	
adicional 4 661 4 1854,3566,7737,9449,	
1% 8 661 8 1849,2094,2098,2149,7732,7977,7981,8032,	
situación 1 661 1 5542,	
3% 6 661 6 1845,1903,2030,7728,7786,7913,	
placebo/metformina 2 661 2 1841,7724,	
ejercieron 1 661 1 5203,	
comparación 16 661 16 1836,1890,2021,2081,2139,2375,4177,4849,4915,4960,7719,7773,7904,7964,8022,8257,	
sitagliptina/metformina 6 661 6 1834,1888,1916,7717,7771,7799,	
semanas 23 661 23 1803,1988,2042,2106,2164,2329,3340,3347,3561,3625,3700,5304,7686,7871,7925,7989,8047,8211,9223,9230,9444,9508,9584,	
24 20 661 20 1802,1987,2041,2105,2163,2328,3346,3560,3624,3699,7685,7870,7924,7988,8046,8210,9229,9443,9507,9583,	
controlado 6 661 6 1798,3626,3701,7681,9509,9585,	
tomaban 2 661 2 1792,7675,	
comunicados 2 661 2 1780,7663,	
pioglitazona 7 661 7 1775,2120,3578,3902,7658,8003,9461,	
parte 4 661 4 1767,2825,7650,8707,	
sangre 2 661 2 1754,7637,	
glucosa 30 661 30 1752,2800,2841,2846,2905,2929,2958,2976,3022,3114,3143,3150,3173,3314,3322,7635,8683,8723,8728,8787,8811,8841,8859,8905,8997,9026,9033,9056,9197,9205,	
descenso 2 661 2 1747,7630,	
REVISIÓN 1 661 1 5893,	
complementarias 2 661 2 1746,7629,	
Exploraciones 2 661 2 1745,7628,	
periférico 2 661 2 1732,7626,	
edema 2 661 2 1731,7625,	
generales 2 661 2 1730,7624,	
abdominal 2 661 2 1725,7619,	
dolor 4 661 4 1724,2320,7618,8202,	
flatulencia 2 661 2 1720,7614,	
diarrea 2 661 2 1715,7609,	
gastrointestinales 4 661 4 1714,2444,7608,8327,	
nervioso 2 661 2 1709,7603,	
sistema 4 661 4 1708,2828,7602,8710,	
Frecuente 10 661 10 1705,1719,1721,1723,1733,7599,7613,7615,7617,7627,	
frecuente 12 661 12 1702,1704,1712,1717,1727,1751,7596,7598,7606,7611,7621,7634,	
Muy 4 661 4 1701,1703,7595,7597,	
hipoglucemia* 2 661 2 1700,7594,	
relación 9 661 9 2243,2277,3368,3598,4201,8126,8159,9251,9481,	
nutrición 2 661 2 1699,7593,	
Trastornos 8 661 8 1693,1706,1713,1729,7587,7600,7607,7623,	
adversa 3 661 3 1684,1736,7578,	
Cambio 4 661 4 3805,3809,3955,3959,	
controlados 7 661 7 1680,1759,2585,3793,7574,7642,8468,	
identificadas 2 661 2 1676,7570,	
Frecuencia 5 661 5 1672,1685,1737,7566,7579,	
Tabla 5 661 5 1670,3274,3784,7564,9157,	
estreñimiento 4 661 4 1722,2221,7616,8104,	
000) 2 661 2 1669,7563,	
(< 3 661 3 1667,4885,7561,	
comenzó 1 661 1 4989,	
000); 2 661 2 1663,7557,	
1/10 4 661 4 1659,1668,7553,7562,	
raras 4 661 4 1657,1666,7551,7560,	
1/100); 2 661 2 1656,7550,	
000 4 661 4 1654,1660,7548,7554,	
< 11 661 11 1648,1655,1661,3454,4127,4874,4880,7542,7549,7555,9337,	
1/100 2 661 2 1647,7541,	
1/10); 4 661 4 1644,1649,7538,7543,	
( 8 661 8 1643,1646,1652,1658,7537,7540,7546,7552,	
rica 1 661 1 4325,	
frecuentes 8 661 8 1642,1645,1651,3392,7536,7539,7545,9275,	
1/1 4 661 4 1653,1662,7547,7556,	
definen 2 661 2 1639,7533,	
aumento 9 661 9 2453,2775,4180,4905,5457,5494,5596,8336,8658,	
frecuencias 2 661 2 1637,7531,	
sistemas 2 661 2 1633,7527,	
normativa 1 661 1 5836,	
clasificados 2 661 2 1631,7525,	
1) 3 661 3 1630,5681,7524,	
Reacción 3 661 3 1683,1735,7577,	
notificadas 6 661 6 1598,1931,2190,7492,7814,8073,	
consideradas 2 661 2 1592,7486,	
Las 8 661 8 1589,1636,2783,2822,7483,7530,8666,8704,	
paciente) 8 661 8 1580,1616,1952,2209,7474,7510,7835,8092,	
Incompatibilidades 1 661 1 5737,	
2% 8 661 8 1574,1610,1946,2203,7468,7504,7829,8086,	
(> 8 661 8 1572,1608,1944,2201,7466,7502,7827,8084,	
mayor 8 661 8 1571,1607,1943,2200,7465,7501,7826,8083,	
frecuencia 12 661 12 1570,1606,1635,1942,2199,2287,7464,7500,7529,7825,8082,8169,	
notificaron 2 661 2 1567,7461,	
tratamientos 2 661 2 1548,7442,	
5% 13 661 13 1544,1899,2256,2299,2312,2691,4977,7438,7782,8139,8181,8194,8574,	
8% 2 661 2 1535,7429,	
fármaco 28 661 28 1531,1564,1597,1828,1882,1930,2013,2069,2132,2189,2232,2363,2402,2769,7425,7458,7491,7711,7765,7813,7896,7952,8015,8072,8115,8245,8285,8652,	
relacionadas 27 661 27 1528,1561,1594,1825,1879,1927,2010,2066,2129,2186,2360,2399,3208,5604,7422,7455,7488,7708,7762,7810,7893,7949,8012,8069,8242,8282,9091,	
abandonos 2 661 2 1521,7415,	
tasa 2 661 2 1519,7413,	
metformina) 4 661 4 1510,3247,7404,9130,	
(con 4 661 4 1507,3244,7401,9127,	
recibido 2 661 2 1490,7384,	
700 2 661 2 1487,7381,	
duración 8 661 8 1483,1913,2166,3342,7377,7796,8049,9225,	
grande 2 661 2 1475,7369,	
(N=453) 1 661 1 3879,	
número 4 661 4 1474,3514,7368,9397,	
9 16 661 16 1469,1844,2148,2152,2387,2579,3886,3893,3995,5870,7363,7727,8031,8035,8270,8462,	
adversas 35 661 35 1467,1524,1557,1591,1675,1688,1740,1821,1875,1923,2006,2062,2125,2182,2356,2395,2443,2545,7361,7418,7451,7485,7569,7582,7704,7758,7806,7889,7945,8008,8065,8238,8278,8326,8428,	
8 17 661 17 1465,3820,3830,3838,3860,3870,3883,3907,3917,3930,3974,3975,3992,3993,4297,5858,7359,	
somnolencia 4 661 4 1463,1710,7357,7604,	
mareos 2 661 2 1461,7355,	
notificado 4 661 4 1458,2541,7352,8424,	
cuenta 2 661 2 1454,7348,	
realizado 7 661 7 1431,3278,4820,5167,5577,7325,9161,	
máquinas 6 661 6 1427,1443,1450,7321,7337,7344,	
capacidad 4 661 4 1422,1438,7316,7332,	
7 7 661 7 1418,2097,2801,3863,5838,7312,7980,	
excreción 3 661 3 1403,4651,7297,	
humana 10 661 10 1395,5264,5277,5323,5416,5477,5630,5647,5664,7289,	
materna 5 661 5 1394,1409,5634,7288,7303,	
leche 5 661 5 1393,1408,5670,7287,7302,	
excreta 3 661 3 1390,4459,7284,	
Lactancia 2 661 2 1384,7278,	
embarazo 2 661 2 1383,7277,	
humanos 2 661 2 1376,7270,	
hallazgo 1 661 1 5313,	
régimen 3 661 3 1690,1742,7584,	
Ante 2 661 2 1370,7264,	
humano 7 661 7 1369,2638,4668,5334,5546,7263,8521,	
potencial 2 661 2 1365,7259,	
In 1 661 1 4741,	
desconoce 7 661 7 1362,1386,2715,5325,7256,7280,8598,	
altas 2 661 2 1356,7250,	
reproductiva 2 661 2 1353,7247,	
demostrado 7 661 7 1351,1401,2897,5439,7245,7295,8779,	
animales 6 661 6 1349,1399,2891,7243,7293,8773,	
embarazadas 2 661 2 1345,7239,	
mujeres 2 661 2 1344,7238,	
conejos 1 661 1 5636,	
adecuados 2 661 2 1337,7231,	
lactancia 4 661 4 1332,1416,7226,7310,	
Embarazo 4 661 4 1330,1333,7224,7227,	
concomitantemente 2 661 2 1327,7221,	
administren 2 661 2 1326,7220,	
vigilarse 2 661 2 1320,7214,	
mínimos 3 661 3 2617,4015,8500,	
deberán 2 661 2 1319,7213,	
toxicidad 9 661 9 1316,1352,5247,5364,5509,5589,5633,7210,7246,	
(Tabla 2 661 2 1629,7523,	
presenten 2 661 2 1313,7207,	
embargo 7 661 7 1309,1445,4136,4712,5071,7203,7339,	
Sin 7 661 7 1308,1444,4135,4711,5070,7202,7338,	
18% 2 661 2 1299,7193,	
modestamente 2 661 2 2681,8564,	
plasmática 5 661 5 1295,3315,4909,7189,9198,	
11% 2 661 2 1291,7185,	
farmacoterapéutico 2 661 2 2734,8617,	
promedio 4 661 4 1289,1297,7183,7191,	
plasmático 5 661 5 1282,4291,4343,4932,7176,	
aumentos 2 661 2 2616,8499,	
días 2 661 2 1279,7173,	
10 7 661 7 1278,1848,4111,4465,5889,7172,7731,	
durante 13 661 13 1277,1381,1414,2546,2695,4599,4978,5565,7171,7275,7308,8429,8578,	
diariamente 2 661 2 1276,7170,	
0 16 661 16 1265,1534,1573,1609,1945,2202,3821,3839,3847,3861,7159,7428,7467,7503,7828,8085,	
Tras 5 661 5 1260,4257,4466,4568,7154,	
Digoxina 2 661 2 1248,7142,	
moderado 2 661 2 1243,7137,	
e 7 661 7 1236,3371,3447,4204,7130,9254,9330,	
digoxina 15 661 15 1235,1259,1269,1286,1307,1318,1324,4778,7129,7153,7163,7180,7201,7212,7218,	
plasmáticas 11 661 11 1233,1257,3082,4276,4433,4762,4776,5151,7127,7151,8965,	
concentraciones 16 661 16 1232,1256,2844,3081,3136,3213,4275,4761,4775,5150,7126,7150,8726,8964,9019,9096,	
Sitagliptina 27 661 27 1225,1249,2678,3190,3539,3817,3835,3857,3880,3904,3927,3970,3988,4438,4625,4658,4693,4728,4968,5436,5445,5665,7119,7143,8561,9073,9422,	
(OCT) 2 661 2 1224,7118,	
orgánicos 3 661 3 1223,4666,7117,	
cationes 2 661 2 1222,7116,	
pelicular 1 661 1 5714,	
transportador 3 661 3 1220,4663,7114,	
CYP2C9 2 661 2 1218,7112,	
OCT2 1 661 1 4734,	
sustratos 2 661 2 1214,7108,	
causar 2 661 2 1209,7103,	
propensión 2 661 2 1207,7101,	
escasa 2 661 2 1206,7100,	
fertilidad 1 661 1 5554,	
evidencia 2 661 2 1203,7097,	
tenerse 2 661 2 1452,7346,	
proporcionando 2 661 2 1202,7096,	
orales 4 661 4 1201,2751,7095,8634,	
anticonceptivos 2 661 2 1200,7094,	
ataxia 1 661 1 5377,	
warfarina 2 661 2 1198,7092,	
> 9 661 9 1578,1614,1950,2207,5068,7472,7508,7833,8090,	
rosiglitazona 2 661 2 1197,7091,	
gliburida 2 661 2 1195,7089,	
CYP450 2 661 2 1182,7076,	
glucagón 14 661 14 2790,2937,2944,3002,3037,3110,3133,8673,8819,8826,8885,8920,8993,9016,	
isoenzimas 3 661 3 1180,4548,7074,	
compararon 2 661 2 1915,7798,	
induce 2 661 2 1178,7072,	
peritoneal 2 661 2 2722,8605,	
inhibe 4 661 4 1176,3204,7070,9087,	
vivo 6 661 6 1154,1212,1238,7048,7106,7132,	
considera 4 661 4 1147,2511,7041,8394,	
significtivas 2 661 2 1145,7039,	
probenecid 2 661 2 1138,7032,	
inhibido 2 661 2 1134,7028,	
mediado 3 661 3 1130,4752,7024,	
OAT3 7 661 7 1125,1132,1161,4746,7019,7026,7055,	
sustrato 4 661 4 1118,4696,4732,7012,	
transporte 6 661 6 1112,1127,4690,4751,7006,7021,	
evaluado 4 661 4 1103,1152,6997,7046,	
efectos 13 661 13 1087,1435,2227,2969,4330,5204,5420,5550,5584,6981,7329,8110,8852,	
alterar 2 661 2 1071,6965,	
puedan 2 661 2 1070,6964,	
claritromicina) 2 661 2 1069,6963,	
ritonavir 2 661 2 1068,6962,	
itraconazol 2 661 2 1067,6961,	
ketoconazol 2 661 2 1066,6960,	
potentes 4 661 4 1060,1091,6954,6985,	
posible 2 661 2 1056,6950,	
razón 2 661 2 1054,6948,	
terminal 8 661 8 1051,1085,4608,4893,4955,5016,6945,6979,	
nefropatía 7 661 7 1050,1084,4892,4954,5015,6944,6978,	
caso 8 661 8 1048,1096,2640,2671,6942,6990,8523,8554,	
curso 6 661 6 1040,3876,3900,3923,3946,6934,	
claro 1 661 1 5977,	
frecuentemente 2 661 2 2259,8142,	
eliminación 7 661 7 1035,4644,4675,4707,5811,5813,6929,	
importante 2 661 2 1032,6926,	
papel 2 661 2 1019,6913,	
""112"" 1 661 1 5979,	
pequeño 8 661 8 1018,1228,1252,2452,6912,7122,7146,8335,	
formar 2 661 2 3061,8944,	
sólo 3 661 3 1015,4626,6909,	
vía 4 661 4 1011,4451,5079,6905,	
normal 8 661 8 1006,3027,3035,3508,6900,8910,8918,9391,	
probablemente 1 661 1 5504,	
CYP2C8 5 661 5 1000,1217,4534,6894,7111,	
contribución 2 661 2 998,6892,	
CYP3A4 13 661 13 996,1014,1063,1094,1216,4529,4550,4564,6890,6908,6957,6988,7110,	
metabolismo 12 661 12 991,1008,1026,1695,1967,4449,4524,6885,6902,6920,7589,7850,	
limitado 3 661 3 990,4523,6884,	
responsable 3 661 3 988,4521,6882,	
enzima 7 661 7 987,3052,3200,4520,6881,8935,9083,	
principal 3 661 3 986,4519,6880,	
horas 10 661 10 2704,3327,3329,4284,4624,4987,4991,8587,9210,9212,	
indicaron 3 661 3 983,4516,6877,	
vitro 11 661 11 982,1110,1136,1171,4515,4538,4742,6876,7004,7030,7065,	
in 16 661 16 981,1109,1135,1153,1170,1211,1237,4514,4537,6875,7003,7029,7047,7064,7105,7131,	
Ensayos 6 661 6 980,1108,3814,3852,6874,7002,	
gluproteína 2 661 2 978,6872,	
inhibidores 12 661 12 975,1059,1090,1159,2755,2885,6869,6953,6984,7053,8638,8767,	
importantes 2 661 2 972,6866,	
produzcan 2 661 2 970,6864,	
esperar 2 661 2 967,6861,	
significativa 7 661 7 961,3308,3730,4168,6855,9191,9614,	
diferencia 10 661 10 1577,1613,1949,2206,2459,7471,7507,7832,8089,8342,	
aclaramiento 7 661 7 952,1022,4636,4724,4867,6846,6916,	
El 23 661 23 951,1025,1126,2879,3148,3292,3409,3513,3579,4341,4394,4635,4856,5417,6845,6919,7020,8761,9031,9175,9292,9396,9462,	
significativos 4 661 4 950,2519,6844,8402,	
deterioró 1 661 1 4224,	
consideraron 26 661 26 948,1527,1560,1824,1878,1926,2009,2065,2128,2185,2359,2398,2623,6842,7421,7454,7707,7761,7809,7892,7948,8011,8068,8241,8281,8506,	
cambios 7 661 7 940,2517,3126,3762,6834,8400,9009,	
Estos 2 661 2 939,6833,	
respectivamente 14 661 14 938,1850,1904,2035,2099,2154,2389,6832,7733,7787,7918,7982,8037,8272,	
sesión 3 661 3 2697,4980,8580,	
29% 2 661 2 934,6828,	
aproximadamente 20 661 20 932,2467,2478,2688,4115,4313,4421,4473,4581,4621,4640,4935,4939,5154,5343,5411,6826,8350,8361,8571,	
Cmax 7 661 7 928,1294,4301,4361,4369,6822,7188,	
AUC 7 661 7 926,1284,4290,4342,4931,6820,7178,	
valores 6 661 6 924,3264,5254,5287,6818,9147,	
aumentó 7 661 7 922,1287,3413,4346,6816,7181,9296,	
600 4 661 4 918,2480,6812,8363,	
única 5 661 5 906,916,4409,6800,6810,	
oral 8 661 8 905,915,4260,4469,4574,4613,6799,6809,	
p 14 661 14 894,979,1122,1247,2651,4700,4720,4756,4792,6788,6873,7016,7141,8534,	
glucoproteína 10 661 10 893,1121,1246,4699,4719,4755,4791,6787,7015,7140,	
inhibidor 9 661 9 890,1242,3193,4545,4716,4788,6784,7136,9076,	
potente 4 661 4 889,3194,6783,9077,	
ciclosporina 5 661 5 887,921,4714,6781,6815,	
(N=102) 1 661 1 3926,	
(-0 4 661 4 3829,3869,3892,3916,	
cabo 2 661 2 878,6772,	
simvastatina 2 661 2 1196,7090,	
llevó 2 661 2 876,6770,	
Ciclosporina 2 661 2 874,6768,	
farmacocinética 18 661 18 865,897,943,1073,1192,4333,4798,4830,5091,5119,5128,5209,5228,6759,6791,6837,6967,7086,	
supresión 2 661 2 2997,8880,	
significativamente 5 661 5 863,1190,4242,6757,7084,	
observaron 7 661 7 2516,2615,5279,5388,5549,8399,8498,	
alteró 6 661 6 862,958,1189,6756,6852,7083,	
veces 21 661 21 853,2340,3711,3724,3967,3985,5261,5274,5293,5320,5345,5413,5432,5474,5523,5627,5644,6747,8222,9595,9608,	
1000 5 661 5 848,3721,3997,6742,9605,	
repetidas 3 661 3 846,4634,6740,	
coadministración 7 661 7 836,843,901,4319,6729,6737,6795,	
significativas 4 661 4 833,3548,6726,9431,	
ligera 2 661 2 5393,5396,	
clínicamente 19 661 19 832,949,1144,2512,2518,2624,2707,3257,4912,5115,5205,6725,6843,7038,8395,8401,8507,8590,9140,	
interacciones 8 661 8 831,971,1143,1210,6724,6865,7037,7104,	
sugieren 5 661 5 826,1172,5657,6719,7066,	
continuación 4 661 4 825,1628,6718,7522,	
comparaba 1 661 1 4051,	
descritos 4 661 4 823,2233,6716,8116,	
fármacos 4 661 4 817,1167,6710,7061,	
Efectos 6 661 6 814,1162,1419,6707,7056,7313,	
interacción 2 661 2 813,6706,	
formas 4 661 4 811,3085,6704,8968,	
Interacción 2 661 2 804,6697,	
alternativo 2 661 2 797,6690,	
establecer 2 661 2 791,6684,	
7% 2 661 2 2388,8271,	
acontecimiento 2 661 2 789,6682,	
potenciales 2 661 2 787,6680,	
causas 2 661 2 786,6679,	
evaluar 9 661 9 784,882,3282,3630,4828,6677,6776,9165,9513,	
reacción 2 661 2 775,6668,	
sospecha 2 661 2 772,6665,	
hay 6 661 6 771,1335,2627,6664,7229,8510,	
después 5 661 5 765,4285,4402,4992,6658,	
sucedieron 2 661 2 764,6657,	
inicio 2 661 2 757,6650,	
meses 2 661 2 754,6647,	
primeros 2 661 2 753,6646,	
tres 2 661 2 752,6645,	
ocurrió 2 661 2 749,6642,	
aparición 2 661 2 745,6638,	
Stevens-Johnson 4 661 4 743,2572,6636,8455,	
síndrome 4 661 4 741,2570,6634,8453,	
incluido 2 661 2 739,6632,	
piel 4 661 4 738,2567,6631,8450,	
exfoliativas 4 661 4 735,2564,6628,8447,	
enfermedades 4 661 4 734,2563,6627,8446,	
angioedema 4 661 4 732,2558,6625,8441,	
conducir 8 661 8 1424,1440,1447,3178,7318,7334,7341,9061,	
anafilaxia 4 661 4 731,2557,6624,8440,	
incluyen 2 661 2 730,6623,	
graves 2 661 2 720,6613,	
postautorización 2 661 2 717,6610,	
toleraron 2 661 2 2601,8484,	
recogido 2 661 2 715,6608,	
interés 1 661 1 5539,	
han 20 661 20 714,1102,1350,1400,1430,1457,1489,2540,3277,5166,5350,6607,6996,7244,7294,7324,7351,7383,8423,9160,	
Se 24 661 24 713,875,1361,1385,2539,2714,3276,3348,3619,4487,4818,5244,5278,5324,5631,6606,6769,7255,7279,8422,8597,9159,9231,9502,	
hipersensibilidad 8 661 8 712,722,777,2555,6605,6615,6670,8438,	
Reacciones 4 661 4 710,1466,6603,7360,	
deben 2 661 2 701,6594,	
Como 2 661 2 687,6580,	
Insuficiencia 4 661 4 685,4816,5031,6578,	
insulina 24 661 24 684,2862,2917,2922,2951,2995,3016,3104,3131,3167,3372,4205,4218,6577,8744,8799,8804,8834,8878,8899,8987,9014,9050,9255,	
adecuadamente 2 661 2 676,6569,	
superior 9 661 9 642,1728,2309,2425,4373,6535,7622,8191,8308,	
Poco 8 661 8 1711,1716,1726,1750,7605,7610,7620,7633,	
incidencia 27 661 27 638,1818,1872,2003,2059,2122,2308,2352,2391,3394,3606,3774,4231,5460,5497,5599,6531,7701,7755,7886,7942,8005,8190,8234,8274,9277,9489,	
combina 2 661 2 633,6526,	
placebo 47 661 47 630,646,1624,1682,1793,1800,2086,2179,2217,2381,2464,3333,3408,3437,3477,3491,3555,3600,3618,3628,3693,3703,3795,4033,4035,6523,6539,7518,7576,7676,7683,7969,8062,8100,8263,8347,9216,9291,9320,9360,9374,9438,9483,9501,9511,9576,9587,	
tratados 62 661 62 628,703,725,1552,1586,1601,1622,1832,1886,1934,1958,2017,2024,2073,2084,2135,2143,2194,2215,2262,2291,2366,2379,2405,3400,3435,3594,3614,3677,3691,4161,4187,6521,6596,6618,7446,7480,7495,7516,7715,7769,7817,7841,7900,7907,7956,7967,8018,8026,8077,8098,8145,8173,8248,8261,8288,9283,9318,9477,9497,9560,9574,	
Estas 3 661 3 728,5200,6621,	
similares 8 661 8 621,1784,3473,3494,6514,7667,9356,9377,	
notificados 6 661 6 617,2239,2273,6510,8122,8155,	
(incluso 2 661 2 2665,8548,	
índices 8 661 8 614,624,1777,1787,6507,6517,7660,7670,	
pioglitazona) 2 661 2 612,6505,	
conocido 2 661 2 607,6500,	
hipoglucemiente 2 661 2 605,6498,	
combinada 2 661 2 599,6492,	
biodisponibilidad 1 661 1 4307,	
terapia 6 661 6 598,2331,3705,6491,8213,9589,	
Metformina 2 661 2 841,6735,	
monoterapia 19 661 19 595,1763,2160,3227,3291,3304,3502,3737,3792,3816,4086,6488,7646,8043,9110,9174,9187,9385,9621,	
clínicos 18 661 18 591,822,1186,1471,1679,1758,2448,2584,2685,6484,6715,7080,7365,7573,7641,8331,8467,8568,	
ensayos 46 661 46 590,1185,1347,1397,1432,1470,1517,1678,1757,1906,2158,2447,2497,2583,2684,3280,3336,3500,3558,3603,3790,3797,4513,5168,5443,5587,6483,7079,7241,7291,7326,7364,7411,7572,7640,7789,8041,8330,8380,8466,8567,9163,9219,9383,9441,9486,	
antihiperglucemiantes 4 661 4 587,2750,6480,8633,	
medicamentos 9 661 9 586,601,808,838,6479,6494,6701,6731,9642,	
Hipoglucemia 2 661 2 577,6470,	
diabética 2 661 2 576,6469,	
cetoacidosis 2 661 2 575,6468,	
3) 3 661 3 1360,3919,7254,	
utilizarse 6 661 6 561,1379,1412,6454,7273,7306,	
Generales 2 661 2 558,6451,	
especiales 5 661 5 555,5750,5758,5809,6448,	
precauciones 2 661 2 554,6447,	
Advertencias 2 661 2 552,6445,	
8) 6 661 6 549,650,801,6442,6543,6694,	
activo 2 661 2 536,6429,	
previsible 1 661 1 5083,	
principio 2 661 2 535,6428,	
68% 2 661 2 937,6831,	
Hipersensibilidad 2 661 2 533,6426,	
material 2 661 2 2655,8538,	
Contraindicaciones 2 661 2 532,6425,	
eficacia 8 661 8 529,3284,3632,4053,4150,6422,9167,9515,	
falta 5 661 5 522,1372,4148,6415,7266,	
18 7 661 7 517,2093,3339,4045,6410,7976,9222,	
secreta 1 661 1 5667,	
indican 2 661 2 1626,7520,	
menores 2 661 2 515,6408,	
niños 2 661 2 514,6407,	
utilizar 8 661 8 511,1426,1442,1449,6404,7320,7336,7343,	
pediátrica 2 661 2 507,6400,	
Población 2 661 2 506,6399,	
precaución 2 661 2 505,6398,	
actuarse 2 661 2 503,6396,	
limitados 2 661 2 500,6393,	
son 10 661 10 499,2803,2847,2975,3174,6392,8685,8729,8858,9057,	
años 7 661 7 498,518,1481,5746,6391,6411,7375,	
75 2 661 2 497,6390,	
bajos 2 661 2 3175,9058,	
disponibles 2 661 2 492,6385,	
seguridad 14 661 14 491,527,3287,3460,3634,4056,5243,5521,5653,6384,6420,9170,9343,9517,	
datos 16 661 16 489,524,821,1169,1336,1374,4536,5132,5219,5231,6382,6417,6714,7063,7230,7268,	
Los 22 661 22 488,820,1086,1168,1346,1396,2968,3675,4159,4512,4535,4896,5139,5586,6381,6713,6980,7062,7240,7290,8851,9558,	
función 12 661 12 484,1004,1030,3358,3506,5105,5188,6377,6898,6924,9241,9389,	
precisa 5 661 5 478,5035,5098,5181,6371,	
avanzada 3 661 3 475,5143,6368,	
edad 9 661 9 474,487,496,5108,5110,5142,6367,6380,6389,	
estudiado 4 661 4 464,675,6357,6568,	
hepática 14 661 14 445,457,470,2959,5032,5047,5063,5087,5250,5510,6338,6350,6363,8842,	
2) 11 661 11 441,671,709,3275,3512,5030,6334,6564,6602,9158,9395,	
5 19 661 19 440,708,803,1359,1734,2723,3511,3823,4128,4191,4252,5238,5762,6333,6601,6696,7253,8606,9394,	
población 3 661 3 435,4003,6328,	
indica 1 661 1 4781,	
recomienda 7 661 7 428,510,1302,4998,6321,6403,7196,	
Por 8 661 8 424,651,962,1052,6317,6544,6856,6946,	
limitada 7 661 7 423,691,3049,5026,6316,6584,8932,	
primera 3 661 3 768,5882,6661,	
grave 17 661 17 421,471,699,1045,1081,3523,4884,4948,5010,5064,5088,6314,6364,6592,6939,6975,9406,	
moderada 12 661 12 419,460,697,3521,4877,4929,5008,5050,6312,6353,6590,9404,	
clínico 7 661 7 411,1107,2664,4768,6304,7001,8547,	
ensayo 38 661 38 410,880,1106,1797,1853,1985,2039,2103,2326,2605,3272,3424,3440,3622,3696,4049,4134,4199,4767,4822,4857,5301,5570,6303,6774,7000,7680,7736,7868,7922,7986,8208,8488,9155,9307,9323,9505,9580,	
experiencia 10 661 10 408,689,2548,2628,5020,5057,6301,6582,8431,8511,	
combinado 1 661 1 5217,	
ajuste 11 661 11 402,450,480,1303,5037,5100,5183,6295,6343,6373,7197,	
requiere 5 661 5 400,448,5756,6293,6341,	
ml/min) 7 661 7 397,3456,4876,4882,4887,6290,9339,	
50 18 661 18 396,857,2344,2348,3455,3708,3971,3989,4881,5786,5925,5946,6289,6751,8226,8230,9338,9592,	
[CrCl] 2 661 2 395,6288,	
creatinina 5 661 5 394,3453,4869,6287,9336,	
(aclaramiento 4 661 4 392,3451,6285,9334,	
reacciones 41 661 41 719,729,748,1523,1556,1590,1674,1687,1739,1820,1874,1922,2005,2061,2124,2181,2355,2394,2442,2544,2553,6612,6622,6641,7417,7450,7484,7568,7581,7703,7757,7805,7888,7944,8007,8064,8237,8277,8325,8427,8436,	
leve 7 661 7 391,458,4871,4901,5048,6284,6351,	
En 55 661 55 386,588,1001,1183,1468,1515,1549,1756,1795,1851,1905,1983,2037,2101,2324,2445,2603,2639,2682,3116,3215,3438,3601,3694,4047,4197,4765,4923,5335,5452,5568,6279,6481,6895,7077,7362,7409,7443,7639,7678,7734,7788,7866,7920,7984,8206,8328,8486,8522,8565,8999,9098,9321,9484,9578,	
renal 40 661 40 385,390,418,686,696,953,1005,1044,1080,1099,3449,3507,3519,4637,4652,4676,4708,4725,4817,4846,4863,4900,4928,4947,5007,5080,5248,6278,6283,6311,6579,6589,6847,6899,6938,6974,6993,9332,9390,9402,	
insuficiencia 33 661 33 384,389,417,444,456,469,695,1043,1079,1098,3448,3518,4845,4862,4899,4927,4946,5006,5046,5062,5086,6277,6282,6310,6337,6349,6362,6588,6937,6973,6992,9331,9401,	
Pacientes 6 661 6 382,442,472,6275,6335,6365,	
alcanzar 2 661 2 2295,8177,	
alimentos 3 661 3 380,4340,6274,	
acodadas) 1 661 1 5612,	
incluyendo 7 661 7 1009,2556,2568,5011,6903,8439,8451,	
doble 2 661 2 370,6264,	
No 38 661 38 365,446,461,476,508,559,672,1149,1300,1334,1410,1428,2514,2626,4353,4679,4996,5033,5055,5096,5164,5179,5547,5738,6259,6339,6354,6369,6401,6452,6565,7043,7194,7228,7304,7322,8397,8509,	
acuerde 2 661 2 364,6258,	
paciente 2 661 2 362,6256,	
tomarse 6 661 6 358,367,376,6252,6261,6270,	
omite 2 661 2 352,6246,	
Si 7 661 7 350,770,2705,2842,6663,8588,8724,	
4) 2 661 2 349,3832,	
hemoglobina 2 661 2 3138,9021,	
apartado 21 661 21 347,439,544,648,669,707,799,1358,2574,3510,5028,6242,6332,6437,6541,6562,6600,6692,7252,8457,9393,	
(ver 23 661 23 346,438,543,647,668,706,798,1357,2573,3273,3509,5027,6241,6331,6436,6540,6561,6599,6691,7251,8456,9156,9392,	
hipoglucemia 22 661 22 345,616,640,667,1779,2220,3040,3180,3396,3609,3776,4233,6240,6509,6533,6560,7662,8103,8923,9063,9279,9492,	
riesgo 13 661 13 343,665,829,1141,1314,1364,5659,6238,6558,6722,7035,7208,7258,	
reducir 4 661 4 341,663,6236,6556,	
baja 7 661 7 337,659,2986,4435,6232,6552,8869,	
dar 4 661 4 333,655,6228,6548,	
considerarse 6 661 6 332,654,2710,6227,6547,8593,	
Cuando 4 661 4 322,631,6217,6524,	
concomitante 6 661 6 321,1157,1263,6216,7051,7157,	
constantes 2 661 2 2522,8405,	
administrarse 2 661 2 318,6213,	
debe 18 661 18 317,357,366,502,560,778,1378,1411,1451,6212,6251,6260,6395,6453,6671,7272,7305,7345,	
posología 2 661 2 307,6202,	
mantenerse 2 661 2 305,6200,	
Debe 2 661 2 304,6199,	
glipizida 8 661 8 4070,4092,4103,4125,4158,4189,4229,4249,	
día 39 661 39 303,373,855,1498,1540,1812,1866,1997,2051,2118,2175,2342,2812,3302,3545,3713,3828,3845,3867,3890,3914,3937,4068,6198,6267,6749,7392,7434,7695,7749,7880,7934,8001,8058,8224,8694,9185,9428,9597,	
vez 27 661 27 301,1810,1864,1995,2049,2116,2173,3300,3543,3640,3826,3843,3865,3888,3912,3935,4066,6196,7693,7747,7878,7932,7999,8056,9183,9426,9523,	
100 38 661 38 298,908,1272,1493,1537,1805,1859,1936,1990,2044,2111,2168,3295,3540,3818,3836,3858,3881,3905,3928,4061,4265,4412,4615,6193,6802,7166,7387,7431,7688,7742,7819,7873,7927,7994,8051,9178,9423,	
náuseas 2 661 2 1718,7612,	
La 35 661 35 292,407,744,842,900,2390,2761,3041,3064,3393,3654,3738,3773,4099,4230,4306,4424,4606,4643,4797,5109,5812,5896,6187,6300,6637,6736,6794,8273,8644,8924,8947,9276,9537,9622,	
x 1 661 1 5787,	
efecto 13 661 13 604,884,1229,1253,4772,5114,5270,5310,5528,6497,6778,7123,7147,	
administración 10 661 10 291,1156,1262,4259,4405,4570,4605,6186,7050,7156,	
forma 8 661 8 289,320,960,4482,4630,6184,6215,6854,	
Inhibidor 2 661 2 2735,8618,	
Posología 2 661 2 287,6182,	
tiazolidinadiona) 2 661 2 250,6145,	
ej 8 661 8 248,609,1065,2652,6143,6502,6959,8535,	
(p 6 661 6 247,608,1064,6142,6501,6958,	
PPAR 10 661 10 246,259,277,313,1514,6141,6154,6172,6208,7408,	
agonista 10 661 10 245,258,276,312,1513,6140,6153,6171,6207,7407,	
agentes 2 661 2 221,6116,	
dual 2 661 2 218,6113,	
intolerancia 2 661 2 189,6084,	
o 64 661 64 188,310,378,420,459,537,611,698,1046,1082,1199,1448,1500,1508,1511,1774,2347,2524,2849,2883,3210,3237,3245,3617,3647,3665,3720,3758,4034,4069,4338,4556,4594,5009,5049,5193,5394,6083,6205,6272,6313,6352,6430,6504,6591,6940,6976,7093,7342,7394,7402,7405,7657,8229,8407,8731,8765,9093,9120,9128,9500,9530,9548,9604,	
corresponde 1 661 1 5271,	
contraindicaciones 2 661 2 187,6082,	
debido 9 661 9 185,519,2439,2482,4145,6080,6412,8322,8365,	
adecuada 2 661 2 184,6079,	
* 3 661 3 1755,4000,7638,	
sea 4 661 4 183,251,6078,6146,	
tolerada 2 661 2 167,6062,	
máxima 2 661 2 166,6061,	
dosis 59 661 59 165,293,335,354,369,404,452,482,657,769,845,904,914,1305,1355,2590,2608,2630,2694,3465,4100,4123,4263,4288,4352,4367,4379,4408,4468,4573,4612,4633,4825,4833,5040,5103,5186,5401,5514,6060,6188,6230,6248,6263,6297,6345,6375,6550,6662,6739,6798,6808,7199,7249,8473,8491,8513,8577,9348,	
sulfonilurea 20 661 20 150,170,200,330,339,636,661,1506,1960,3243,6045,6065,6095,6225,6234,6529,6554,7400,7843,9126,	
adecuado 10 661 10 139,177,227,252,284,6034,6072,6122,6147,6179,	
vías 2 661 2 2868,8750,	
logren 8 661 8 135,173,223,280,6030,6068,6118,6175,	
sola 16 661 16 133,171,2419,2428,2437,3646,3664,3757,3772,6028,6066,8302,8311,8320,9529,9547,	
tratamiento 51 661 51 130,217,273,572,759,781,793,1491,1692,1744,1769,1839,1893,2534,2675,2880,3293,3419,3565,3783,3799,3854,3874,3898,3921,3944,4022,4037,4082,4144,4227,5358,5607,6025,6112,6168,6465,6652,6674,6686,7385,7586,7652,7722,7776,8417,8558,8762,9176,9302,9448,	
(EMEA) 1 661 1 5914,	
añadida 6 661 6 3643,3868,3896,3915,3938,9526,	
ejercicio 8 661 8 126,161,213,270,6021,6056,6108,6165,	
dieta 8 661 8 123,158,210,267,6018,6053,6105,6162,	
casos 12 661 12 118,153,205,262,763,1459,6013,6048,6100,6157,6656,7353,	
metformina 52 661 52 115,132,181,202,309,610,851,1194,1504,1773,1816,1870,2057,2338,2373,2412,2418,3234,3571,3653,3668,3717,3749,3756,3878,3950,3978,3996,4084,6010,6027,6076,6097,6204,6503,6745,7088,7398,7656,7699,7753,7940,8220,8255,8295,8301,9117,9454,9536,9551,9601,9633,	
combinación 56 661 56 113,147,197,255,327,582,682,1502,1771,1814,1868,1999,2053,2077,2088,2109,2333,2369,2408,3232,3240,3250,3569,3576,3651,3715,3745,3856,4039,6008,6042,6092,6150,6222,6475,6575,7396,7654,7697,7751,7882,7936,7960,7971,7992,8215,8251,8291,9115,9123,9133,9452,9459,9534,9599,9629,	
glucémico 19 661 19 111,138,145,176,195,226,283,2765,3219,4078,6006,6033,6040,6071,6090,6121,6178,8648,9102,	
control 24 661 24 110,137,144,175,194,225,282,1588,2764,3218,4077,4855,4922,4967,6005,6032,6039,6070,6089,6120,6177,7482,8647,9101,	
neural 1 661 1 5365,	
mejorar 8 661 8 108,142,192,2898,6003,6037,6087,8780,	
elevado 1 661 1 5518,	
· 8 661 8 106,140,190,253,6001,6035,6085,6148,	
tipo 19 661 19 104,236,567,872,2894,3120,3185,3445,3536,4814,5999,6131,6460,6766,8776,9003,9068,9328,9419,	
mellitus 4 661 4 103,235,5998,6130,	
diabetes 19 661 19 102,234,566,796,871,2893,3119,3184,3444,4813,5997,6129,6459,6689,6765,8775,9002,9067,9327,	
pacientes 122 661 122 100,232,387,415,437,454,467,494,564,627,693,724,869,1002,1077,1311,1477,1488,1551,1585,1600,1621,1790,1831,1885,1933,1957,2016,2072,2134,2142,2193,2214,2261,2290,2365,2378,2404,3117,3182,3399,3434,3442,3504,3516,3538,3593,3613,3676,3690,3769,4005,4074,4120,4152,4160,4186,4796,4811,4840,4860,4890,4897,4925,4944,4952,5004,5023,5044,5060,5172,5178,5995,6127,6280,6308,6330,6347,6360,6387,6457,6520,6586,6617,6763,6896,6971,7205,7371,7382,7445,7479,7494,7515,7673,7714,7768,7816,7840,7899,7955,8017,8025,8076,8097,8144,8172,8247,8260,8287,9000,9065,9282,9317,9325,9387,9399,9421,9476,9496,9559,9573,	
indicado 4 661 4 98,230,5993,6125,	
está 7 661 7 97,229,3048,5902,5992,6124,8931,	
Xelevia 66 661 66 96,228,295,323,356,374,406,413,432,465,512,562,593,705,727,761,783,1275,1342,1380,1413,1496,1761,2265,2293,2305,2536,2744,3289,3402,4064,4321,4334,5002,5042,5170,5991,6123,6190,6218,6250,6268,6299,6306,6325,6358,6405,6455,6486,6598,6620,6654,6676,7169,7236,7274,7307,7390,7644,8147,8175,8187,8419,8627,9172,9285,	
terapéuticas 4 661 4 95,3214,5990,9097,	
Indicaciones 2 661 2 94,5989,	
	4 2 661 2 92,5987,	
CLÍNICOS 2 661 2 91,5986,	
DATOS 3 661 3 90,5683,5985,	
4 53 661 53 89,285,348,530,545,546,548,550,551,649,670,800,802,1328,1417,1464,2100,2575,2576,2578,2703,2759,3908,3977,4283,4623,4986,4990,5029,5680,5748,5984,6180,6243,6423,6438,6439,6441,6443,6444,6542,6563,6693,6695,7222,7311,7358,7983,8458,8459,8461,8586,8642,	
" 2 661 2 88,5983,	
cara 2 661 2 87,5982,	
""221"" 1 661 1 84,	
rosa 1 661 1 82,	
color 2 661 2 81,5975,	
Sharp 1 661 1 5846,	
redondo 2 661 2 79,5973,	
Comprimido 2 661 2 75,5969,	
(comprimido) 2 661 2 74,5968,	
recubierto 4 661 4 71,76,5965,5970,	
	"Comprimido 2 661 2 70,5964,	
FARMACÉUTICA 2 661 2 69,5963,	
FORMA 2 661 2 68,5962,	
3 15 661 15 67,531,2036,2701,3910,3931,4667,4984,5239,5741,5745,5961,6424,7919,8584,	
6 19 661 19 65,1329,2033,2264,2479,3841,3933,5431,5682,5735,5740,5747,5761,5806,5807,5959,7223,7916,8362,	
sección 2 661 2 64,5958,	
mostraron 4 661 4 1113,4164,5593,7007,	
ver 2 661 2 63,5957,	
excipientes 5 661 5 62,542,5689,5956,6435,	
completa 2 661 2 60,5954,	
lista 2 661 2 59,5953,	
consultar 2 661 2 57,5951,	
Para 4 661 4 56,3006,5950,8889,	
equivale 2 661 2 50,5944,	
monohidrato 2 661 2 48,5942,	
sitagliptina 165 661 165 47,55,316,619,634,680,819,860,867,899,911,930,945,955,993,1024,1037,1075,1115,1129,1164,1174,1187,1322,1388,1405,1554,1603,1765,1782,1808,1862,1939,1993,2047,2075,2114,2171,2196,2336,2371,2410,2427,2436,2597,2613,2717,3065,3099,3153,3222,3298,3421,3468,3488,3533,3563,3596,3616,3636,3657,3707,3747,3771,4087,4141,4163,4221,4238,4270,4294,4310,4345,4415,4427,4457,4472,4486,4511,4526,4541,4577,4618,4646,4678,4692,4710,4727,4743,4769,4783,4800,4836,4911,4934,5074,5093,5121,5153,5211,5562,5581,5941,5949,6211,6512,6527,6573,6712,6754,6761,6793,6805,6824,6839,6849,6887,6918,6931,6969,7009,7023,7058,7068,7081,7216,7282,7299,7448,7497,7648,7665,7691,7745,7822,7876,7930,7958,7997,8054,8079,8218,8253,8293,8310,8319,8480,8496,8600,8948,8982,9036,9105,9181,9304,9351,9371,9416,9446,9479,9499,9519,9540,9591,9631,	
fosfato 2 661 2 45,5939,	
contiene 2 661 2 44,5938,	
comprimido 3 661 3 43,5692,5937,	
	Cada 2 661 2 42,5936,	
nM 1 661 1 4305,	
CUANTITATIVA 2 661 2 41,5935,	
Y 2 661 2 40,5934,	
CUALITATIVA 2 661 2 39,5933,	
COMPOSICIÓN 2 661 2 38,5932,	
2 33 661 33 37,105,237,286,381,873,1480,1486,1982,2895,3121,3186,3326,3335,3446,3785,4253,4815,5736,5931,6000,6132,6181,6767,7374,7380,7865,8777,9004,9069,9209,9218,9329,	
película 8 661 8 36,73,78,5784,5792,5930,5967,5972,	
recubiertos 4 661 4 34,5782,5790,5928,	
notificaciones 2 661 2 716,6609,	
comprimidos 4 661 4 33,5781,5789,5927,	
mg 71 661 71 32,53,299,849,858,909,919,1267,1273,1494,1538,1806,1860,1937,1991,2045,2112,2169,2346,2595,2611,2634,3296,3541,3638,3709,3719,3722,3819,3837,3859,3882,3906,3929,3972,3980,3990,3998,4062,4112,4266,4413,4616,5926,5947,6194,6743,6752,6803,6813,7161,7167,7388,7432,7689,7743,7820,7874,7928,7995,8052,8228,8478,8494,8517,9179,9424,9521,9593,9603,9606,	
adición 3 661 3 3655,4059,9538,	
25 4 661 4 31,52,1266,7160,	
	Xelevia 2 661 2 30,5924,	
MEDICAMENTO 4 661 4 29,2728,5923,8611,	
interrumpirse 1 661 1 779,	
NOMBRE 2 661 2 27,5921,	
1 33 661 33 25,26,66,93,568,1543,1579,1615,1671,1794,1951,2208,2730,2791,3884,3940,4195,4281,5686,5788,5920,5960,5988,6461,7437,7473,7509,7565,7677,7834,8091,8613,8674,	
PRODUCTO 1 661 1 24,	
DEL 4 661 4 23,28,5894,5922,	
grupo 7 661 7 2315,4107,4139,4156,4236,4247,8197,	
CARACTERÍSTICAS 1 661 1 22,	
LAS 1 661 1 21,	
DE 10 661 10 20,2726,5840,5843,5860,5862,5872,5876,5891,8609,	
RESUMEN 1 661 1 19,	
O 1 661 1 18,	
TÉCNICA 1 661 1 17,	
FICHA 1 661 1 16,	
tuvo 9 661 9 1226,1250,4329,4370,4383,4770,5112,7120,7144,	
información 2 661 2 13,5897,	
Toda 2 661 2 11,4001,	
medicamento 5 661 5 10,15,5754,5815,5901,	
Basica 1 661 1 8,	
	Información 1 661 1 7,	
PELIC 1 661 1 6,	
CON 1 661 1 5,	
RECUB 1 661 1 4,	
COMPRIMIDOS 1 661 1 3,	
50X1 1 661 1 2,	
100MG 1 661 1 1,	
XELEVIA 1 661 1 0,	
